Retatrutide, by Soma Chems , represents a significant development in body control . This unique compound combines GLP-1 receptor function with gut-derived pathway stimulation , demonstrating remarkable potential in trial findings for body reduction . Experts believe the drug could represent a alternative pathway for patients struggling with obesity